The VA’s methicillin-resistant Staphylococcus aureus (MRSA) prevention initiative reduced healthcare-associated MRSA infections 69% in VA acute care facilities and 81% in spinal cord injury units in five years. The VA hopes to see similar success in preventing infections with Clostridium difficile (CDI) and carbapenem-resistant Enterobacteriaceae (CRE) — and the MRSA bundle itself may help them do that.
Lower immunization rates have increased the number of U.S. outbreaks of vaccine-preventable diseases, even of those considered eradicated in this country, such as measles.
Research Contradicts Other Recent Findings By Brenda L. Mooney PHILADELPHIA — As the latest influenza season finally abates, a new VA study raises questions about how effective the high-dose vaccine really is for the 65 or older cohort. Beginning at… Read More
Amid all the outcry over the high cost of new hepatitis C therapies, including congressional hearings, a simple fact has been overlooked: The VA expects to save money in the long run because of the drugs’ high cure rates. By… Read More
By Brenda L. Mooney BOSTON – Rates of serologic testing for hepatitis B (HBV) at the VA fail to meet levels recommended by the American Association for the Study of Liver Diseases (AASLD) practice guideline, according to new research. Researchers… Read More
Higher Pneumonia Vaccine Rates Urged By Brenda L. Mooney PROVIDENCE, RI – With influenza season each year comes an even greater challenge for VA hospitals — a spate of pneumonia cases in older veterans. Recent research suggests the problem will… Read More
Free Shots Available at Walgreen’s Locations By Annette M. Boyle SAN FRANCISCO – The VA typically has influenza vaccination rates well above the national average but is trying some innovative measures to do even better. As part of the effort to increase immunizations,… Read More
By Annette M. Boyle WASHINGTON – While commercial insurers responded to the approval of the breakthrough drug sofosbuvir for hepatitis C (HCV) by implementing prescribing restrictions, limiting use to the sickest patients and charging higher co-pays because of the drug’s… Read More
By Stephen Spotswood WASHINGTON – When the first Infectious Disease Clinic took place at the Washington, DC, VAMC in 1985, only a handful of HIV-infected patients took advantage. In fact, the disease hadn’t even been named “human immunodeficiency virus;” that… Read More
By Brenda L. Mooney PITTSBURGH – Will hepatitis C become a rare disease over the next two decades or so? The answer is yes, according to a computer simulation conducted by the University of Pittsburgh Graduate School of Public Health… Read More
SAN ANTONIO – The largest ever military investigation of rabies exposure involved more than 900 Air Force personnel interviewed and 200 receiving post-exposure prophylaxis (PEP) at a cost of about $400,000.
WASHINGTON – As the U.S. public health community desperately seeks to help contain what experts say is the largest Ebola outbreak in history and the first in West Africa, DoD also is monitoring the situation closely and has created an internal task force to “further review the situation.”
By Brenda L. Mooney DALLAS – The suspected link between azithromycin and an increased incidence of cardiovascular events was borne out in a recent VA study of veterans hospitalized with pneumonia, but that was only part of the story: The… Read More
By Brenda L. Mooney IOWA CITY, IA – In addition to increasing mortality and morbidity, surgical-site infections (SSIs) nearly double the cost of treatment of patients at the VA yet usually are preventable with good infection-control practices, according to a… Read More
By Brenda L. Mooney COLUMBIA, SC — Veterans prescribed amoxicillin over a nearly 13-year period were less likely to be diagnosed with potentially fatal heart rhythms than those using either azithromycin or levofloxacin, according to new research. The study, published… Read More
By Brenda L. Mooney LEXINGTON, KY — The VA requirement to obtain nasal surveillance swabs on all patients at hospital admission, unit-to-unit transfer and discharge appears to be a key component of the continued decline in methicillin-resistant Staphylococcus aureus (MRSA)… Read More
By Annette M. Boyle Jeffery McCombs, PhD LOS ANGELES — While achieving undetectable viral loads reduces the risk of death associated with hepatitis C by 45% and other adverse liver-related complications by 27%, only 4% of eligible patients in a… Read More
By Annette M. Boyle David Ross, MD, PhD WASHINGTON — New therapies for hepatitis C (HCV) are pouring out of the pharmaceutical pipeline and promising effective treatment with fewer side effects for many of the 170,000 veterans with chronic HCV… Read More
By Annette M. Boyle Amy Justice, MD, Ph.D NEW HAVEN, CT — With human immunodeficiency virus (HIV) now being treated more like diabetes, hypertension and other chronic diseases, HIV patients face some of the same issues as other veterans dealing… Read More